[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志,2021,37(4):311-398.
[2] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-66.
[3] Schnurr TM, Jakupovi H, Carrasquilla GD, et al.Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: A case-cohort study[J].Diabetologia,2020,63(9995):1324-1332 .
[4] 冯静,刘欢,许丹,等. 肥胖2型糖尿病患者合并血脂异常和高血压情况分析[J].中国全科医学, 2019,22(S1):64-66.
[5] 周丽诺, 俞茂华, 李红,等. 肥胖和非肥胖2型糖尿病患者的临床特点及影响其心功能的多因素探讨[J]. 中国糖尿病杂志, 2002(3):135-138.
[6] 刘星, 刘秀荣, 杨春伟,等. 腹型肥胖对糖尿病人群新发高尿酸血症影响的研究[J]. 中国糖尿病杂志, 2014, 22(11):970-973.
[7] 夏阳阳, 顾天伟, 蒋春明, 等. 2型糖尿病患者发生慢性肾脏病的危险因素及与肥胖的相关性研究[J]. 中华糖尿病杂志, 2022, 14(2):140-146.
[8] Yi M, Chen RP, Yang R, et al.Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China[J]. Diabet Med, 2017,34(4):505-513.
[9] 母义明,杨文英, 朱大龙,等.磺脲类药物临床应用专家共识(2016年版)[J]. 药品评价, 2017, 14(1):5-12,54.
[10] Lean ME, Leslie WS, Barnes AC, et al.Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomized trial[J]. Lancet,2018,391(10120):541-551.
[11] Zhang F, Luo W, Shi Y, et al.Should we standardize the 1,700-year-old fecal microbiota transplantation?[J]. Am J Gastroenterol, 2012, 107(11):1755-1755.
[12] Vrieze A, Nood EV, Fuentes S, et al.Duodenal infusion of donor feces for recurrent clostridium difficile[J]. N Engl J Med, 2013.368(5):407-415.
[13] 中华医学会. 肥胖症基层诊疗指(2019)[J]. 中华全科医师杂志,2020,19(2):102-107.
[14] 中华医学会内分泌学分会,中华中医药学会糖尿病分会,中国医师协会外科医师分会,肥胖和糖尿病外科医师委员会,中国研究型医院学会糖尿病与肥胖外科专业委员会.基于临床的肥胖症多学科诊疗共识(2021年版).中华消化外科杂志. 2021,20(11):1137-1152.
[15] Le Chatelier E, Nielsen T, Qin J, et al.Richness of human gut microbiome correlates with metabolic markers[J]. Nature, 2013, 500(7464):541-546.
[16] Ridaura VK, Faith JJ, Rey FE, et al.Gut microbiota from twins discordant for obesity modulate metabolism in mice[J]. Science, 2013, 341(6150):1241214.
[17] Kootte RS, Vrieze A, Holleman F, et al.The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus[J].Diabetes Obes Metab,2012,14(2) :112-120.
[18] Vrieze A, Nood V, Holleman F, et al.Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J].Gastroenterology,2012,143(4):913-916.
[19] Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al.High-fat diet determines the composition of the murine gut microbiome independently of obesity[J]. Gastroenterology, 2009, 137(5):1716-1724.
[20] David LA, Maurice CF, Carmody RN, et al.Diet rapidly and reproducibly alters the human gut microbiome[J]. Nature, 505(7484):559-563.
[21] Singh R, Nieuwdorp M, Berge IT, et al.The potential beneficial role of faecal microbiota transplantation in diseases other than clostridium difficile infection[J]. Clin Microbiol Infect, 2015, 20(11):1119-1125.
[22] Mocanu V, Zhang Z, Deehan EC, et al.Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: A randomized double-blind, placebo-controlled phase 2 trial[J]. Nature Medicine,2021,27(7):1272-1279.
[23] Mullish BH, Nabil QM, Segal JP, et al.The use of faecal microbiota transplant as treatment for recurrent or refractory infection and other potential indications: Joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines[J]. Gut, 2018,67(11):1920-1941.
[24] Cammarota G, Ianiro G, Kelly CR, et al.International consensus conference on stool banking for faecal microbiota transplantation in clinical practice[J]. Gut, 2019, 68(12):2111-2121.
[25] Haifer C, Kelly CR, Paramsothy S, et al.Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice[J]. Gut, 2020, 69(5):801-810.
[26] Zhang S, Wu P, Tian Y, et al.Gut microbiota serves a predictable outcome of short-term low-carbohydrate diet (LCD) intervention for patients with obesity[J]. Microbiol Spectr,2021,9(2):e0022321.
[27] 张雪莹, 陈启仪, 李宁, 等. 菌群移植适应证的选择和临床应用策略[J]. 中华胃肠外科杂志,2020,23(5): 509-515.
[28] Jobin, Christian.Precision medicine using microbiota[J]. Science, 2018,359(6371):32-34.
[29] Mc Donald LC, Gerding DN, Johnson S, et al.Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)[J].Clin Infect Dis, 2018, 66(7):987-994.
[30] 李宁,田宏亮,陈启仪,等.菌群移植治疗肠道疾病2 010例疗效分析[J].中华胃肠外科杂志,2019,22(9):861-868.
[31] 张发明, 刘亚飞. 洗涤菌群移植途径选择的证据与决策[J]. 中华胃肠外科杂志, 2020, 23(Z1):45-47.
[32] Kim HN, Yun YJ, Ryu S, et al.Correlation between gut microbiota and personality in adults: A cross-sectional study[J]. Brain Behav Immun, 2018, 69(12):374-385.
[33] Lai CY, Sung J, Cheng F, et al.Systematic review with meta-analysis: Review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation[J].Aliment Pharmacol Ther, 2019, 49(4):354-363.
[34] Ding C, Fan W, Gu L, et al.Outcomes and prognostic factors of fecal microbiota transplantation in patients with slow transit constipation: results from a prospective study with long-term follow-up[J]. Gastroenterology Report, 2018, 6(2):101-107.
[35] 张薛磊, 田宏亮, 马春联, 等. 阶段性菌群移植治疗顽固性便秘疗效观察[J].中华胃肠外科杂志,2017, 20(12):1355-1359.
[36] 中华医学会肠外肠内营养学分会, 中国国际医疗保健促进交流会加速康复外科分会, 中国微生态治疗创新联盟,等. 菌群移植标准化方法学的建立与临床应用中国专家共识[J]. 中华胃肠外科杂志, 2020, 23(Z1):5-13.
[37] 中国超重肥胖医学营养治疗专家共识编写委员会. 中国超重/肥胖医学营养治疗专家共识(2016年版)[J]. 中华糖尿病杂志, 2016,8(9):525-540.
[38] Gong Q, Zhang P, Wang J, et al.Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study[J]. Lancet Diabetes Endocrinol,2019,7(6):452-461.
[39] 中华预防医学会微生态学分会.中国微生态调节剂临床应用专家共识(2020版)[J].中华临床感染病杂志, 2020, 13(4):241-256.
[40] 中华预防医学会微生态学分会.中国消化道微生态调节剂临床应用专家共识(2016版)[J].中华消化杂志, 2016, 36(12):793-804.
[41] Ruan Y, Sun J, He J, et al.Effect of probiotics on glycemic control: A systematic review and meta-analysis of randomized, controlled trials[J].PLoS One, 2015,10(7):e132121.
[42] Reynolds A, Mann J, Cummings J, et al.Carbohydrate quality and human health: A series of systematic reviews and meta-analyses[J]. Lancet, 2019, 393(10170):434-445.
[43] Mocanu V, Zhang Z, Deehan EC, et al.Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: A randomized double-blind, placebo-controlled phase 2 trial[J]. Nat Med,2021, 27(7): 1272-1279. |
粤公网安备 44011302000297号 